Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

2019 Journal of the National Comprehensive Cancer Network 1,534 citations

Abstract

The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis, risk stratification and workup, treatment options for localized disease, and management of recurrent and advanced disease for clinicians who treat patients with prostate cancer. The portions of the guidelines included herein focus on the roles of germline and somatic genetic testing, risk stratification with nomograms and tumor multigene molecular testing, androgen deprivation therapy, secondary hormonal therapy, chemotherapy, and immunotherapy in patients with prostate cancer.

Keywords

MedicineProstate cancerOncologyNomogramInternal medicineRisk stratificationDiseaseAndrogen deprivation therapyClinical PracticeImmunotherapyHormonal therapyCancerIntensive care medicineFamily medicine

MeSH Terms

Disease ManagementDisease SusceptibilityHumansMaleProstatic Neoplasms

Affiliated Institutions

Related Publications

Overdiagnosis in Cancer

This article summarizes the phenomenon of cancer overdiagnosis-the diagnosis of a "cancer" that would otherwise not go on to cause symptoms or death. We describe the two prerequ...

2010 JNCI Journal of the National Cancer I... 1543 citations

Publication Info

Year
2019
Type
article
Volume
17
Issue
5
Pages
479-505
Citations
1534
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1534
OpenAlex
73
Influential
1004
CrossRef

Cite This

James L. Mohler, Emmanuel S. Antonarakis, Andrew J. Armstrong et al. (2019). Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network , 17 (5) , 479-505. https://doi.org/10.6004/jnccn.2019.0023

Identifiers

DOI
10.6004/jnccn.2019.0023
PMID
31085757

Data Quality

Data completeness: 86%